• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    HEALTHCARE (NY:XLV)

    145.39 +0.29 (+0.20%)
    Streaming Delayed Price Updated: 10:27 AM EDT, May 18, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about HEALTHCARE

    < Previous 1 2 Next >
    News headline image
    Defensive Sectors: Shielding Your Portfolio in Volatile Times
    Defensive sectors like consumer staples, healthcare, real estate, and utilities tend to perform well during market downturns and heightened volatility. 
    Via MarketBeat
    Topics Economy Stocks
    News headline image
    Amgen's MariTide Weight Loss Potential: Stock Outlook
    Amgen's shares fell 2.4% after-hours trading due to a mixed earnings release. MariTide, the company's weight loss drug, is in Phase II FDA trials. 
    Via MarketBeat
    Topics Intellectual Property
    News headline image
    MarketBeat Week in Review – 7/29 - 8/2
    The tech-led sell-off expanded and accelerated to close the week; more volatility may be the norm for the rest of the summer, which may force the Fed to move 
    Via MarketBeat
    Topics Economy Stocks
    News headline image
    Top 2 Cheap Healthcare Stocks to Buy as Sector Outperforms
    The healthcare sector, represented by the XLV ETF, has seen a resurgence, breaking out of a multi-year consolidation phase and surging almost 3% in July. 
    Via MarketBeat
    Topics ETFs
    News headline image
    Pharma Leader Beats on Earnings, But Shares Fall
    Novartis released its Q2 financial results. It beat expectations on EPS and revenue. However, shares fell, possibly due to bad news on one upcoming drug. 
    Via MarketBeat
    Topics Intellectual Property
    News headline image
    The Top 3 Sectors Poised For Growth This Summer
    Communications, technology, and healthcare are the three hottest sectors for growth, but not all stocks will rise with the tides. 
    Via MarketBeat
    Topics ETFs
    News headline image
    Hims & Hers Health Stock Could Become a Wealth Compounder
    Hims & Hers stock could give investors the best of both stability and double-digit upside through EPS projections and price targets, especially after 1Q24 
    Via MarketBeat
    Topics Economy
    News headline image
    CVS Stock is Nearing a 52-Week Low, Better Buy Than Walgreens?
    CVS stock is making its way above Walgreens as a potential watchlist addition. Fundamentals and price targets see the stock making a comeback this year. 
    Via MarketBeat
    News headline image
    Citi’s Results Say This About The Stock Market
    Investors now have an inside look at what one of Wall Street's biggest names is doing with its money. Corporations and clients all see new highs in stocks 
    Via MarketBeat
    Topics Economy
    News headline image
    3 High Dividend Socks to Replace Lower Savings Yields Ahead
    Three stocks stand out as the most attractive dividend propositions, particularly now that savings yields may drop as a result of the Fed's rate cuts 
    Via MarketBeat
    Topics Economy
    News headline image
    Nvidia's AI Tech Part of Novo Nordisk's New Supercomputer
    Novo Nordisk and Nvidia have teamed up to develop supercomputers, aiming to accelerate drug discovery development using advanced AI technologies. 
    Via MarketBeat
    Topics Artificial Intelligence
    News headline image
    bluebird bio Stock Signals Potential to be a Multi-bagger
    Driving a bargain of a short squeeze play, Bluebird Bio stock could soon announce what every investor is hoping to hear, here's what management could do 
    Via MarketBeat
    Topics Economy
    News headline image
    bluebird bio stock is ripe for a 400% institutional short squeeze
    Bluebird Bio stock could be on the verge of a 400% pop on earnings, management has set the writing on the wall for institutional buying to trickle in 
    Via MarketBeat
    Topics Economy
    News headline image
    S&P 500 rockets to new highs as earnings beat estimates
    The S&P 500 hits new highs as 10 of the 11 S&P sectors report positive Q4 earnings surprises. The tech and energy sectors are among the earnings leaders. 
    Via MarketBeat
    Topics ETFs Earnings Stocks
    News headline image
    Can financial, healthcare, energy stocks rise as rates stay high?
    Sectors including financials, healthcare, utilities and energy outperform as interest rates remain high, but some of those industries face challenges in 2024. 
    Via MarketBeat
    News headline image
    Markets suddenly price Eli Lilly stock for a breakout on earnings
    The healthcare sector could see a sudden inflow of investment dollars, and Eli Lilly quickly becomes a favorite name in the space as markets and analysts bid up 
    Via MarketBeat
    Topics Bonds Economy
    News headline image
    Pfizer’s earnings growth trade at a deep discount, suddenly a buy
    The healthcare sector is set to attract a new inflow of investment dollars, as seen in business activity and employment. Pfizer is the clear sector favorite 
    Via MarketBeat
    Topics Economy
    News headline image
    5 top healthcare stocks for earnings growth in 2024
    2024 holds promise for healthcare stocks, with Humana, Elevance, and others expected to boost earnings, as analysts say many industry pressures have been removed. 
    Via MarketBeat
    News headline image
    Are CVS store closures prescription for better financial health?
    CVS plans to close dozens of Target pharmacies starting in February. Amid retail pharmacy challenges, CVS is shifting toward the managed-care industry. 
    Via MarketBeat
    Topics Economy
    News headline image
    UnitedHealth's rising premiums could cushion stubborn inflation
    The healthcare sector is one of the prime suspects to attract safety-seeking investors in the coming market shift. Within it, THIS stock can prove a winner 
    Via MarketBeat
    Topics Economy
    News headline image
    AstraZeneca: Rebound in 2024 with double-digit earnings growth
    AstraZeneca's stock rose 8.95% in the past month on a bullish outlook, driven by growing sales of cancer and diabetes drugs and a strategic acquisition 
    Via MarketBeat
    News headline image
    HCA Healthcare Rallies: Weight-loss drugs really a big threat?
    HCA Healthcare rebounds amid concerns about weight-loss drugs' impact. The healthcare giant's revenue growth hints at resilience despite sector challenges. 
    Via MarketBeat
    Topics ETFs
    News headline image
    Are defensive sectors ready to outshine growth in 2024?
    Is 2024 the year defensive stocks rotate into leadership? As the year gets underway, defensives such as healthcare, energy, utilities and consumer staples lead. 
    Via MarketBeat
    News headline image
    Align Technology: Protected by more factors than any other stock
    Jobs are flowing to the healthcare space, and investment dollars are finding a home in stocks like Align Technology, even the CEO thought it to be the best 
    Via MarketBeat
    News headline image
    Pfizer's chaotic year wraps up with plunging stock, grim guidance
    Pfizer's tumultuous 2023 included a 41.84% stock plunge as revenue from Covid drugs fell. Disappointing 2024 guidance resulted in analysts slashing targets. 
    Via MarketBeat
    News headline image
    Mega merger in the works? Humana, Cigna explore big deal
    Humana and Cigna are exploring a merger, aiming to conclude the deal before year-end, creating a healthcare giant with a potential market value of $137 billion. 
    Via MarketBeat
    News headline image
    These are the top sectors for blue chip growth in 2024
    The sector results will be mixed in 2024 but the Health Care, Communications and Technology sectors (and some of their stocks) will post robust gains. 
    Via MarketBeat
    Topics Economy Intellectual Property
    News headline image
    J&J, Gilead, BMS: A look at undervalued dividend payers
    J&J, Gilead and Bristol Myers are among healthcare stocks with defensive qualities amid market volatility and a potential economic slowdown 
    Via MarketBeat
    News headline image
    Investor patience tested as pharmaceutical stocks take a tumble
    The healthcare sector faces a selloff as pharmaceutical giants report lackluster earnings; even Amgen's strong results failed to prevent selling in the sector 
    Via MarketBeat
    News headline image
    J&J stock down as business unit mulls talc-related bankruptcy
    Johnson & Johnson stock fell in the past week as talc-related lawsuits weigh on a subsidiary, which is mulling bankruptcy to mitigate payouts and settlements. 
    Via MarketBeat
    Topics Bankruptcy Lawsuit
    < Previous 1 2 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.